Attractive Location For Pharmaceutical R&D And Manufacturing

BMI View: In BMI's Business Environment Ratings for Q211, Belgium scored 64.5 out of a total of 100 in BMI's, placing it fifth in the western Europe matrix. Although growth in medicine sales is low, the country has a very large market in absolute terms. Furthermore, per-capita spending is high and there is a sizeable pensionable population - factors which we believe will continue to bring in substantial income for companies operating in the

To read the full article, please choose one of the following options: